Matches in Nanopublications for { ?s ?p "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP328559.RAeuzkLJqAKDLkt0h5Q4zCYBLtoqvGffsjPXTY7MqNCyA130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328559.RAeuzkLJqAKDLkt0h5Q4zCYBLtoqvGffsjPXTY7MqNCyA130_provenance.
- NP674293.RAUBPBboviw5psOkD8iNxHGHx_1WUOlzunDcpfftcERvg130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674293.RAUBPBboviw5psOkD8iNxHGHx_1WUOlzunDcpfftcERvg130_provenance.
- NP794316.RAyrr6liMQlHw0DyYMVskypljnc7HPtEy3SKvwohQbBFg130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794316.RAyrr6liMQlHw0DyYMVskypljnc7HPtEy3SKvwohQbBFg130_provenance.
- assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP977448.RACD5G22MBWOaeg6sQmT7DKTzMWGTYwG2e7D1crwUyqDU130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977448.RACD5G22MBWOaeg6sQmT7DKTzMWGTYwG2e7D1crwUyqDU130_provenance.
- NP977451.RACsBvmwuAcuEee1Pn7EMRFfSz-k0JKA40Xn85HtdL9Xw130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977451.RACsBvmwuAcuEee1Pn7EMRFfSz-k0JKA40Xn85HtdL9Xw130_provenance.
- NP977446.RAs6IDp28_s0VDwimyLMagcqh7jOR-CrWSZONvFYAH0Zo130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977446.RAs6IDp28_s0VDwimyLMagcqh7jOR-CrWSZONvFYAH0Zo130_provenance.
- NP594851.RAqZgl39PIkRn-5C7zZ9SsReBAhs3Bxt2y5bKhVpNp6ks130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594851.RAqZgl39PIkRn-5C7zZ9SsReBAhs3Bxt2y5bKhVpNp6ks130_provenance.
- NP594852.RAI-VGu1E9JCTCJCIPt8_nEH18LkgfeIBdLQEdMr72XKg130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594852.RAI-VGu1E9JCTCJCIPt8_nEH18LkgfeIBdLQEdMr72XKg130_provenance.
- NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_provenance.